James J Biagi (James Biagi)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Squamous Cell Carcinoma

Top Venues

JCO oncology practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew C Hynes, James J Biagi, Aamer Mahmud, Yuka Asai
Unilateral porokeratosis associated with neoadjuvant radiotherapy of the pelvis. International journal of dermatology (2024)
Remy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé, Juan Lucio Iovanna, Pascal Hammel, Vinciane Rebours, Anthony Turpin, Meher Ben Abdelghani, Alice C Wei, Emmanuel Mitry, Anthony Lopez, James J Biagi, Eric François, Pascal Artru, Aurélien Lambert, Daniel J Renouf, Laure Monard, Marjorie Mauduit, Nelson J Dusetti, Thierry Conroy, Jerome Cros
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Adrienn N Bourkas, Alexandre Menard, Emidio Tarulli, Leah Jodoin, James J Biagi
Impact of an Accelerated Diagnostic Assessment Program on the Timeliness of Cancer Diagnosis and Treatment. JCO oncology practice (2023)
Sheron Perera, Gun Ho Jang, Yifan Wang, Deirdre Kelly, Michael J Allen, Amy Zhang, Robert E Denroche, Anna Dodd, Stephanie Ramotar, Shawn Hutchinson, Mustapha Tehfé, Ravi Ramjeesingh, James J Biagi, Bernard Lam, Julie M Wilson, Sandra E Fischer, George Zogopoulos, Faiyaz Notta, Steven J Gallinger, Robert C Grant, Jennifer J Knox, Grainne M O'Kane
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)